Please login to the form below

Not currently logged in
Email:
Password:

antibiotics

This page shows the latest antibiotics news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

At the moment, patients need to be admitted to hospital for both topical and systemic drug treatment, including potent immunosuppressants, anti-TNF drugs to tackle inflammation and antibiotics to prevent infection,

Latest news

More from news
Approximately 54 fully matching, plus 274 partially matching documents found.

Latest Intelligence

  • #OrkambiNow? #OrkambiNow?

    antibiotics to treat these.

  • Combining therapies and combining research Combining therapies and combining research

    Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more

  • Nudge-nudge, think-think Nudge-nudge, think-think

    practices and simply explained that they were prescribing antibiotics at a higher rate than other practices in their area.

  • Rules of engagement Rules of engagement

    countries highlighted people’s unfamiliarity with the language of antibiotic resistance. ... Only one-fifth were aware of its abbreviated form  ‘AMR’. By contrast, more than two-thirds knew of the terms ‘antibiotic resistance’ or ‘drug

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

More from intelligence
Approximately 5 fully matching, plus 34 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Francesco Maria Lavino joins to support commercialisation of its new antibiotic. ... He said: “Nabriva Therapeutics is poised to introduce what is potentially the first new class of antibiotics for systemic human use in nearly two decades.

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    development. He said: “The resistance to antibiotics is becoming a global issue that needs to be addressed and I believe Destiny has a significant part to play.

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    Regulatory authorities have recognised the potential that Allecra’s novel antibiotic may contribute towards solving the crisis of resistant bacterial infections, and out lead development programme has been significantly expedited. ... With these new

  • Micreos appoints chief medical officer Micreos appoints chief medical officer

    In his new role Dr Frieling will be responsible for overseeing Micreos' antibiotic alternative, Staphefekt, as it begins clinical trials.

  • Nabriva Therapeutics adds Will Sargent to team Nabriva Therapeutics adds Will Sargent to team

    He said: “I am excited to join this talented and dedicated team focused on advancing a novel, targeted antibiotic therapy that can impact patients' lives by addressing an unmet medical need.

More from appointments
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics